Free Trial
→ Warning: Elon’s $20k Robot Might Replace Your Nanny (From WealthPress) (Ad) Free ENTO Stock Alerts

Entero Therapeutics (ENTO) SEC Filings & 10K Form

Entero Therapeutics logo
$0.49 -0.03 (-4.82%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.50 +0.00 (+0.55%)
As of 02/21/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Entero Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/13/2025
3:59 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Paolone Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:00 PM		Corbett Eric (Reporting)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:02 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Uppal Manpreet (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
3:31 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:18 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:23 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:15 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
6:31 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
4:00 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:10 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
6:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:05 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
4:00 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
4:28 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
7:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
7:05 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form NT 10-Q
08/14/2024
8:46 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Ramdeen Timothy R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:20 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
9:54 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:16 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/23/2024
3:05 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
7:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
1:33 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
SAPIRSTEIN JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:34 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
7:03 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/20/2024
3:30 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:23 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRER14A
06/14/2024
4:15 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 424B3
06/12/2024
5:23 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
11:15 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form EFFECT
06/05/2024
4:15 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
4:25 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/30/2024
4:18 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K/A
05/30/2024
4:32 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEFA14A
05/16/2024
6:16 AM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:26 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
4:26 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:59 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 424B5
05/08/2024
4:16 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K/A
03/29/2024
3:16 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Critical ‘Buy Now’ Alert on My Favorite Stock! (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>
03/22/2024
4:00 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:40 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:31 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEFA14A
03/15/2024
5:00 PM		First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Syage Jack (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/15/2024
5:00 PM		First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/15/2024
5:05 PM		First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
5:05 PM		First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Syage Jack (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
5:10 AM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEFA14A
03/14/2024
5:09 AM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
4:29 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ENTO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...
Altimetry | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
A strange twist 500 miles from Washington
Energy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...
Porter & Company | Sponsored